Lampela Pasi, Soininen Päivi, Urtti Arto, Männistö Pekka T, Raasmaja Atso
Department of Pharmacology and Toxicology, University of Kuopio, FIN-70211 Kuopio, Finland.
Int J Pharm. 2004 Feb 11;270(1-2):175-84. doi: 10.1016/j.ijpharm.2003.10.004.
We have reported earlier that a combination of low-molecular weight polyethylenimines (PEIs) with the cationic liposome, Dosper, results in a synergistic increase in the transfection efficiency. Now we have investigated whether this synergism is a general mechanism seen with other transfection reagents as well. Therefore, we have combined the low-molecular weight PEIs (MW 700 and 2000) with Dotap (a monocationic liposome), Lipofectamine (a combination of neutral and polycationic liposome), and Superfect (a dendrimer). The highest synergism was achieved with Lipofectamine and PEIs in the SMC cells, or with Dotap and PEIs in the C6 cells. Superfect did not induce any synergism. The combinations did not cause any changes in DNA condensing ability measured with ethidium bromide exclusions. The proton pump inhibitor, bafilomycin A1, had similar effects in both cell lines. Interestingly, the combination of Dosper (a positive control) and PEI caused the most effective transfection synergism in the presence of serum, although Lipofectamine, with or without PEIs, was a very potent reagent demonstrating the best transfection efficiency in the absence of serum. It is suggested that the PEI/Dosper-mediated synergism in the transfection efficiency may be a general mechanism for liposomal transfection reagents, although the effects can vary depending on cell lines.
我们之前报道过,低分子量聚乙烯亚胺(PEIs)与阳离子脂质体Dosper联合使用可协同提高转染效率。现在我们研究了这种协同作用是否也是其他转染试剂常见的机制。因此,我们将低分子量PEIs(分子量700和2000)与Dotap(一种单阳离子脂质体)、Lipofectamine(一种中性和聚阳离子脂质体的组合)以及Superfect(一种树枝状聚合物)进行了联合。在平滑肌细胞中,Lipofectamine与PEIs联合使用时协同作用最强;在C6细胞中,Dotap与PEIs联合使用时协同作用最强。Superfect未诱导出任何协同作用。这些组合对通过溴化乙锭排除法测定的DNA凝聚能力没有任何影响。质子泵抑制剂巴弗洛霉素A1在两种细胞系中的作用相似。有趣的是,尽管在无血清条件下Lipofectamine(无论有无PEIs)是表现出最佳转染效率的非常有效的试剂,但在有血清存在的情况下,Dosper(阳性对照)与PEI的组合导致了最有效的转染协同作用。提示PEI/Dosper介导的转染效率协同作用可能是脂质体转染试剂的普遍机制,尽管其效果可能因细胞系而异。